For instance, it is reported that 4-1BB signaling in CD19 CAR T cells, unlike CD28, produces positive feedback on the gammaretroviral long terminal repeat (LTR) promoter through NF-κB activation, resulting in CAR T cell apoptosis and inefficient anti-tumor performance [32]. This evidence concerns the gene CD28 and neoplasm.